Katie Heller

April 27, 2021
Dr. O'Dwyer and Dr. Schnall

From the Co-Chairs, April 2021

With cherry blossoms finished weeks ago, and fragrant magnolia blooms littering paths, Philadelphia is well into spring, and that means it must be time for an ECOG-ACRIN Group Meeting
April 27, 2021

Trial Spotlight: Search for patients intensifies with the opening of a new NCI-MATCH treatment arm

In this interview, Dr. Peter O'Dwyer urges physicians, sites, and testing laboratories to redouble efforts to locate patients for 12 open arms
April 27, 2021
Healthcare professional at laptop

Virtual Spring 2021 Group Meeting: Tips and Highlights

Most of us are virtual meeting pros by now—and though many miss the connection and energy of in-person events, there is something to be said for attending sessions in sweatpants, a favorite coffee mug in hand
April 27, 2021
Sylvester Comprehensive Cancer Center exterior

Institution Spotlight: Sylvester Comprehensive Cancer Center at the University of Miami

A Standing Main Member of ECOG-ACRIN since 2005
April 27, 2021
News in Brief

News in Brief, April 2021

March 31, 2021
Dr. O'Dwyer and Dr. Schnall

From the Co-Chairs, March 2021

What will 'clean-up' and recovery after COVID-19 entail?
March 31, 2021
Doctor patient skin exam

Now Enrolling: EA6194 for Operable Melanoma

This phase II study, led by Dr. Ahmad Tarhini, is testing neoadjuvant treatment with pembrolizumab alone versus pembrolizumab and an investigational drug called CMP-001
March 31, 2021
Doctor listening to patient's lungs

Now Enrolling: PrE0506 / DREAM3R for Patients with Malignant Pleural Mesothelioma

This phase III study, led by Drs. Patrick Forde and Anna Nowak, is evaluating durvalumab immunotherapy during and after standard chemotherapy versus chemotherapy alone
March 31, 2021
Female doctor consulting with older male patient

Trial Spotlight: Amer Zeidan on the BLAST MRD CML 1 Study for Chronic Myeloid Leukemia

The EA9171 phase II trial aims to determine if adding pembrolizumab immunotherapy to standard-of-care TKI therapy helps more patients achieve undetectable minimal residual disease and allows them to discontinue TKI therapy
March 31, 2021
Puerto Rico map

Institution Spotlight: Puerto Rico Minority Underserved NCORP

A member of ECOG-ACRIN since 1990
March 31, 2021
News in Brief

News in Brief, March 2021

February 25, 2021
Dr. O'Dwyer and Dr. Schnall

From the Co-Chairs, February 2021

COVID-19 vaccination and patients with cancer; the impact of delayed screening; a virtual Spring 2021 Group Meeting